Descripción

Anandamide and 2-AG metabolic enzyme interactions with phytocannabinoids are illustrated. Inhibition of endocannabinoid degradation may enhance endogenous anticonvulsant tone.

Figure 491

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 491: Anandamide and 2-AG metabolic enzyme interactions with phytocannabinoids are illustrated. Inhibition of endocannabinoid degradation may enhance endogenous anticonvulsant tone.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Anandamide and 2-AG metabolic enzyme interactions with phytocannabinoids are illustrated. Inhibition of endocannabinoid degradation may enhance endogenous anticonvulsant tone." />
  <figcaption>Figure 491. Anandamide and 2-AG metabolic enzyme interactions with phytocannabinoids are illustrated. Inhibition of endocannabinoid degradation may enhance endogenous anticonvulsant tone.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Evidencia relacionada

CBD para Insomnio

Calificación A · 103 estudios